A chemical profile of 'ecstasy'. Ring-substituted amphetamine derivates (MDMA and analogs) in Spain;Perfil quimico del 'extasis'. Derivados anfetaminicos de anillo sustituido en Espana

Ars Pharmaceutica

Volumn 38, Issue 1, 1997, Pages 77-92

  Gamella, J F ^a   Alvarez Roldan A ^a   Romo Aviles N ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Amphetamine derivatives; Chemical content; Ethnography; Illicit drugs; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE;

ARTICLE; DRUG DEPENDENCE; DRUG FORMULATION; HEALTH HAZARD; SPAIN;

EID: 6844252884     PISSN: 00042927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. CIS (Centro de Investigaciones Socioligicas): Opiniones y comportamiento de los españoles ante el consumo de drogas, tabaco y alcohol (1994). Estudio n.o 2.080. Madrid.
2. DGPND (Delegacion del Gobierno para el Plan Nacional sobre Drogas). Encuesta escolar sobre drogas, 1994 (1995) Ministerio de Justicia e Interior. Madrid.
3. DE LA FUENTE, L., RODRÍGUEZ ARENAS, M. A., VICENTE, J., SÁNCHEZ PAYA J., BARRIO, G.: "Epidemiología del consumo de drogas de diseño en España". Medicina Clínica (Barc). (1997), 108(2):54-61.
4. LLOPIS, J. J. et al.: "Drogas de diseño, consumo y consumidores: análisis de la demanda al servicio telefónico de drogodependencias. Generalitat Valenciana". Adicciones (1994), 6(4):389-404.
5. GAMELLA, J. F. AND ÁLVAREZ-ROLDÁN, A.: Drogas de síntesis en España. Pautas de adquisición y consumo. Un estudio antropológico en Cinco Comunidades Autónomas (1997). Delegación del Gobierno para el Plan Nacional Sobre Drogas. Madrid. En prensa.
6. ÁLVAREZ-ROLDÁN, A., GAMELLA, J. F. Y SÁNCHEZ, J.: "Ecstasy in Spain: Trends and Patterns of Use". In: Illicit Drugs in Europe" (1997), PROCEEDINGS OF THE SIXTH ANNUAL CONFERENCE ON DRUG USE AND DRUG POLICY. AMSTERDAM (en prensa).
7. GAMELLA, J. F., ÁLVAREZ ROLDÁN, A., ROMO, N.: "La expansión del "éxtasis" en España". En Drogas de síntesis. Elementos para el análisis social, la prevención y la asistencia (1997). COORDINADORA DE ONGs QUE INTERVIENEN EN DROGODEPENDENCIAS. Madrid. (en prensa).
8. Forsyth, A. J. M.: "Places and patterns of drug use in the Scottish dance scene". Addiction (1996), 91(4):511-521.
9. MEASHAM, F., NEWCOMBE, R. AND PARKER, H.: "The normalization of recreational drug use amongst young people in North-West England". British Journal of Sociology (1994), 45(2):287-312.
10. PARKER, H., MEASHAM, F. AND ALDRIDGE, J.: "Drug futures. Changing patterns of drug use amongst English youth" (1995) London: ISDD Research Monograph Seven.
11. KORF, D. J., LETTINK. D.: "Ecstasy: trends and patterns in the Netherlands". In N. J. Kozel (ed.), Epidemiological trends in drug abuse (1994). NIDA (National Institute of Drug Abuse). Rockville, MD.
12. SOLOWIJ, N., HALL, W. AND LEE, N.: "Recreational MDMA use in Sydney: A profile of 'ectasy' users and their experiences with the drug". British Journal of Addiction (1992), 87:1161-1172.
13. BARRIO, G., DE LA FUENTE, L., CAMI, J.: "El consumo de drogas en España y su posición en el contexto europeo". Medicina Clínica (Barc) (1993), 101:344-355.
14. DÍAZ, A. DONCEL, C., BARRUTI, M.: The lines of Success: A Study on the nature and extent of cocaine use in Barcelona (1992). Laboratori de Sociologia y Ajuntament de Barcelona. Barcelona.
15. GAMELLA, J. F.: "Heroína en España, 1977-1996. Balance de una crisis de drogas". Claves de Razón Práctica (1997), 72:20-30.
16. GAMELLA, J. F.: "The Spread of IV Drug Use and AIDS in a neighborhood in Spain". Medical Anthropology Quarterly (1994), 8(2): 131-160.
17. GAMELLA, J. F.: "Los heroinómanos de un barrio de Madrid. Un estudio cuantitativo mediante métodos etnográficos". Antropología (1993), 4:57-101.
18. EISNER, B.: Ecstasy: The MDMA story (1989), Berkeley, CA: Ronin.
19. SHULGIN, A., SHULGIN, T.: PIHKAL. A chemical love story (1992). Transform Press. Berkeley, CA.
20. IJZERMANS, J. N. M., TILANUS, H. W., DE MAN, R. A. AND METSELAAR, H. J.: "Ecstasy and liver transplantation". Annales de Medecine Interne (1993), 144(7):568.
21. KHAKOO, S. I., COLES, C. J., ARMSTRONG, J. S. AND BARRY, R. E.: "Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy')". J Clin Gastroenterol (1995), 20(3):244-247.
22. DYKHUIZEN, R. S., BRUNT, P. W., ATKINSON, P., SIMPSON, J. G. AND SMITH, C. C.: "Ecstasy induced hepatitis mimicking viral hepatitis". Gut (1995), 36:939-941.
23. ELLIS, A. J., WENDON, J. A., PORTMANN, B. AND WILLIAMS, R.: "Acute liver damage and ecstasy ingestion". Gut (1996), 38(3):454-458.
24. DOWLING, G. P., MCDONOUGH, E. T. AND BOST, R. O.: "'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA". JAMA (1987), 257(12):1615-1617.
25. DOWLING, G. P.: "Human deaths and toxic reactions attributed to MDMA and MDEA". In S. J. Peroutka, Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA (1990), Boston: Kluwer.
26. HENRY, J. A., JEFFREYS, K. J., DAWLING, S.: "Toxicity and deaths from 3,4-Methylenedioxymethamphetamine (Ecstasy)", Lancet (1992), 340(8816):384-387.
27. CAMPKIN, N. T. A., DAVIES, U. M.: "Another death from ecstasy". Journal of the Royal Society of Medicine (1992), 85:61.
28. MAXWELL, D. L., POLKEY, M. I., HENRY, J. A.: "Hyponatremia and catatonic stupor after taking ecstasy". British Medical Journal (1993), 307(6916):1399-1399.
29. FORREST, A. R. W., GALLOWAY, J. H., MARSH, I. D., STRACHAN, G. A. AND CLARK, J. C.: "A fatal overdose with 3,4-methylenedioxyamphetamine derivatives". Forensic Science International (1994), 64:57-59.
30. FINESCHI, V. AND MASTI, A : "Fatal poisoning by MDMA (ecstasy) and MDEA: a case report". International Journal of Legal Medicine (1996), 108:272-275.
31. IWERSEN, S., SCHMOLDT, A.: "Two very different fatal cases associated with the use of methylenedioxyethylamphetamine (MDEA): Eve as deadly as Adam". Clinical Toxicology (1996), 34(2):241-244.
32. MILROY, C. M., CLARK, J.C. AND FORREST, A. R. W.: "Pathology of deaths associated with 'ecstasy' and 'eve' misuse". Journal of Clinical Pathology (1996), 49(2):149-153.
33. STEELE, T. D., MCCANN, U. D., RICAURTE, G. A.: "3,4 Methylenedioxymethamphetamine (MDMA, Ecstasy). Pharmacology and toxicology in animals and humans". Addiction (1994), 89(5):539-551.
34. MCCANN, U. D., RIDENOUR, A., SHAHAM, Y., RICAURTE, G. A.: "Serotonin Neurotoxicity After (+/-)3,4-Methylenedioxymethamphetamine (MDMA Ecstasy) - A Controlled-Study in Humans", Neuropsychopharmacology (1994), 10(2):129-138.
35. BALANZO, X., RAFEL, J., DE LA TORRE, R. AND CAMI, J.: "Intoxicación aguda mortal por metilendioxianfetamina". Medicina Clínica (1996), 106(18):718.
36. MUNIESA, M. P. Y ROYO, A. M.: "Acute hepatitis from ingestion of ecstasy". Revista Española de Enfermedades Digestivas (1995), 87(9):681-683.
37. HERRERO, S.: "Aspectos médico-legales del uso y abuso de MDMA y otras drogas psicoestimulantes". In J. BOBES (ed.), Extasis: Aspectos Farmacológicos, Psiquiátricos y Médico-Legales (1995). Barcelona: CITRAN, Ediciones en Neurociencias.
38. NOGGLE, F. T, CLARK, C. R., VALAER, A. K., DE RUITER, J.: "Liquid cromatographic and mass spectral analysis of N-substituted analogues of 3,4-methylenedioxyamphetamine". Journal of Chromatogr Sc (1988), 26:410-415.
39. WOLF ET AL.: "Contents of 'ecstasy'". The Lancet (1995) , 346:1100-1101. Oct. 21.
40. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends January-March 1994 (1994), 103:13.
41. LYTTLE, T., MONTAGNE, M.: "Drugs, Music, and Ideology: A Social Pharmacological Interpretation of the Acid House Movement". The International Journal of the Addictions (1992), 27(10): 1159-1177.
42. REDHEAD, S.: Rave Off: Politics and deviance in contemporary youth culture (1993). Aldershot. Avebury.
43. THORNTON, S.: Club Cultures. Music, Media and Subcultural Capital (1996). Wesleyan University Press. London.
44. "Ketamine/Ephedrine Tablets Appear in Spain". Microgram (December 1995), 28(12):381.
45. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends (1994), 106:1,14.
46. "'Fido Dido' Shows Up in Italy". Microgram (November 1995), 28 (11): 337
47. "MBDB and Steroids in Florida". Microgram (November 1995), 28(11):341.
48. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends June-September 1994, 105:28.
49. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends Oct-Dec 1994, 106:13-14.
50. "LSD, MDA and Analogs in Israel". Microgram (September 1995) 28,9:276-279.
51. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends (1994), 103:26.
52. DIL (DRUG INTELLIGENCE LABORATORY): Drug Abuse Trends January-March (1995), 107:13.
53. "Recent Tablet and Blotter Paper Seizures in Israel" Microgram (December 1995), 28(12):383-385.
54. MORSELLI, O., BOVOLENTA, A., RIPANI, L., GAROFANO L., SCHIAVONE, S.: "'Designer Drugs' in the Italian Clandestine Market: Situation and New Analytical Problems". Microgram (1994), 27(1):28-33.
55. LEIVA, M., TORRES, E., NEGRO, T., DOMÍNGUEZ, L.: "Evolución del tráfico de "drogas de diseño". San, L., Gutiérrez, M., Casas, M., Eds. Alucinógenos. La experiencia psicodélica (1996), 125-142. Citran. Ediciones en Neurociencias. Barcelona.
56. "'Fido Dido' Makes an Appearance in Spain". Microgram (July 1995), 28(7):214.
57. "MBDB Tablets Reported in Spain". Microgram (December 1995), 28(12):382.
58. BENGOECHEA, A., BATLLE, C., BATLLE, A: "Análisis cuantitativo de 3,4-metilendioxianfetamina y sus derivados por HPTLC. Estudio de aprensiones en Cataluna entre 1985 y 1992". II Congreso Iberoamericano de Toxicología y X Jornadas Toxicológicas Españolas. 27-30 de septiembre de 1993, (1993).
59. DEL CASON, T A.: "An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs". Journal of Forensic Sciences (1990), 35(3):675-697.
60. REMBERG, B., NIKIFOROV, A. AND BUCHBAUER, G.: Potential Loopholes in Present Control Strategies. I. Ring substituted amphetamine analogues and their natural synthetic precursors (1994). Viena. UNDCP (United Nations Drug Control Program).